The impact of CYP2C9 and VKORC1 genetic polymorphisms in anticoagulant therapy management after cardiac surgery with extracorporeal circulation

Milena Velizarova, Julieta Hristova, Dobrin Svinarov, Stefka Ivanova, Stefanija Jovinska, Philip Abedinov

Open source

DOI
10.3897/pharmacia.68.e63409
Published
02
Container
Pharmacia
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3897/pharmacia.68.e63409,
  title = {The impact of CYP2C9 and VKORC1 genetic polymorphisms in anticoagulant therapy management after cardiac surgery with extracorporeal circulation},
  author = {Milena Velizarova and Julieta Hristova and Dobrin Svinarov and Stefka Ivanova and Stefanija Jovinska and Philip Abedinov},
  year = {2021},
  journal = {Pharmacia},
  doi = {10.3897/pharmacia.68.e63409},
  url = {https://doi.org/10.3897/pharmacia.68.e63409}
}

RIS

TY  - JOUR
TI  - The impact of CYP2C9 and VKORC1 genetic polymorphisms in anticoagulant therapy management after cardiac surgery with extracorporeal circulation
AU  - Milena Velizarova
AU  - Julieta Hristova
AU  - Dobrin Svinarov
AU  - Stefka Ivanova
AU  - Stefanija Jovinska
AU  - Philip Abedinov
PY  - 2021
JO  - Pharmacia
DO  - 10.3897/pharmacia.68.e63409
UR  - https://doi.org/10.3897/pharmacia.68.e63409
ER  - 

APA

Velizarova, M., Hristova, J., Svinarov, D., Ivanova, S., Jovinska, S., & Abedinov, P. (2021). The impact of CYP2C9 and VKORC1 genetic polymorphisms in anticoagulant therapy management after cardiac surgery with extracorporeal circulation. Pharmacia. https://doi.org/10.3897/pharmacia.68.e63409

Source records